NexavarActive Ingredient(s): Sorafenib Tosylate
FDA Approved: * December 20, 2005
Pharm Company: * BAYER PHARMS
Sorafenib (co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar), is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma. Contents 1 Mechanism of action 2 Medical uses 2.1 Kidney cancer 2.2 Liver cancer 2.3 Thyroid cancer 2.4 Desmoid tumors 3 Adverse effe... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.
I would like to know if anyone is on this med and if it working and how are the side effects? Thank you very much ## Hel...2 REPLIES
Hi. My 18 year old son has AML with flt-3 gene mutation. He has been using a low dose of Nexavar 200mg 2x/day for 2 week...
I talked to my oncologist today and he is going to put me on nexavar I was curious as to the percentage of rate of succe...2 REPLIES
Do you know any one who uses Nexavar lon term for liver cancer? My husband was diagnosed with HCC, and he has been on Ne...